Events

6–8 November, 2017

Beactica participates in BIO-Europe Partnering in Berlin, Germany.

25–29 September, 2017

Beactica presents at Discovery on Target in Boston, US.

12–14 September 2017

Beactica participates in partnering and presents at Nordic Life Science Days in Malmö, Sweden.

1–5 April 2017

Beactica participates in the American Association for Cancer Research’s Annual Meeting in Washington, USA.

20–22 March 2017

Beactica participates in BIO-Europe Spring 2017 in Barcelona, Spain.

5–7 March 2017

Beactica participates in Fragments 2017, the 6th RSC-BMCS Fragment-based Drug Discovery meeting, in Vienna, Austria.

9–12 January 2017

Beactica holds meetings in conjunction with the 35th Annual JP Morgan Healthcare Conference in San Francisco, USA.

7–9 November 2016

Beactica participates in BIO-Europe 2016 in Cologne, Germany.

13–14 September 2016

Beactica participates and presents at Nordic Life Science Days in Stockholm, Sweden.

8-9 September 2016

Beactica participates in 2nd Annual Epigenetics Discovery Congress in London, UK

4-6 April 2016

Beactica participates in BIO-Europe Spring 2016 in Stockholm, Sweden.

11-14 January, 2016

Beactica holds meetings in conjunction with the 34rd Annual JP Morgan Healthcare Conference in San Francisco, USA.

8-10 November, 2015

Beactica presents at the 23rd Protein and Structure Determination in Industry (PSDI) Conference in Munich, Germany.

2-4 November, 2015

Beactica participates in BIO-Europe Partnering 2015 in Munich, Germany.

24-25 September, 2015

Beactica presents a poster at The Epigenetics Discovery Congress in London, UK.

10 September, 2015

Beactica's CEO presents at Nordic Life Science Days in Stockholm, Sweden.

2-3 September, 2015

Beactica's CSO presents at Elrig's Drug Discovery Conference Telford, England.

9-12 June, 2015

Beactica participates in the 2nd NovAliX Conference in Strasbourg, France.

22-24 March, 2015

Beactica participates in Fifth RSC-BMCS Fragment-based Drug Discovery meeting in Cambridge, UK.

21-24 Sept 2014

Beactica participates in Fragment-Based Lead Discovery Conference 2014 in Basel, Switzerland.

7-11 September 2014

Beactica's CSO will hold a key-note lecture at the XXIII International Symposium on Medicinal Chemistry (EFMC-ISMC 2014), in Lisbon, Portugal.

31 August - 4 September

Beactica's CSO will present at the 20th EuroQSAR conference (Understanding Chemical-Biological Interactions) in St Petersburg, Russia. The title of the keynote lecture is "Lead Dicscovery and Optimisation by Use of Interaction Kinetic Analysis".

2-4 July, 2014

Beactica's CSO will present at the 50th annual meeting of the French Medicinal Chemistry Society (SCT), International Conference on Medicinal Chemistry (RICT 2014), in Rouen, France. The topic of the meeting is "Interfacing "Chemical Biology and Drug Discovery".

31 May - 8 June, 2014

Beactica's CSO will present at the 47th crystallographics course ("Structural Basis of Pharmacology: Deeper Understanding of Drug Discovery through Crystallograpy") in Erice, Italy.

8-9 May 2014

Beactica's CSO will present at the Drug Design & Medicinal Chemistry Conference in Berlin, Germany. Preliminary title: "Interaction kinetic analysis for drug discovery –principles and case studies"

23-25 April, 2014

Beactica's CSO will present at Cambridge Healthtech Institute's Ninth Annual Drug Discovery Chemistry conference in San Diego, USA. The preliminary title is "Fragment-Based Discovery of KDM Inhibitors".

20-22 November 2013

Beactica's CSO will present at the 3rd International Symposium - Novel Agents against Infectious Diseases - in Würzburg, Germany.

4-6 November 2013

Beactica participates in BIO-Europe Partnering 2013 in Vienna, Austria.

15-18 October 2013

Beactica's CSO will present at the Biophysics in Drug Discovery Symposium (BφDD 2013) in Strasbourg, France.

14-15 October 2013

Beactica presents at Nordic Life Science Days in Stockholm, Sweden.

15-16 April 2013

Beactica’s CSO presents at the 8th SCI-RSC Symposium on Proteinase Inhibitor Design (Proteinase 2013) in Basel, Switzerland.

19-20 March 2013

Beactica's CSO presents in Fragment Based Lead Discovery at Select Biosciences Discovery Chemistry Congress 2013 in Munich, Germany.

12-14 Nov 2012

Beactica participates in BIO-Europe partnering in Hamburg, Germany.

11-13 Nov 2012

Beactica's CSO presents at PSDI 2012, Chateaux de Montvillargenne, Chantilly, France.

6 Nov 2012

Beactica's CSO presents at the SCI event "Enhancing Drug Quality: The benefits of kinetic and thermodynamic binding data in discovery" in London, UK.

23-26 Sept 2012

Beactica presents at the Fragment-based Lead Discovery Conference (FBLD) 2012 in San Fransisco, USA.

11-12 June 2012

Beactica participates in the 13th Annual Drug Discovery Leaders Summit in Zurich, Switzerland.

30-31 May 2012

Beactica presents at 7th Protein Kinases in Drug Discovery Conference in Boston, USA.

21-22 May 2012

Beactica presents at the EFMC symposium Protein Kinase 2012 in Cambridge, UK.

13-17 May 2012

Beactica presents at 30th Noordwijkerhout-Camerino-Cyprus symposium in Amsterdam, Netherlands.

27-29 March 2012

Beactica participates at the Life Science Investment Day in Malmö, Sweden.

13-14 March 2012

Beactica's CSO presents at Select Bioscience's Discovery Chemistry Congress in Münich, Germany.

13-15 Nov 2011

Beactica participates in Protein Structure Determination in Industry (PSDI) 2011 in Stenungsbaden, Sweden.

17-18 Nov 2011

Beactica's CSO presents at 2011 Nordic Biacore and Micro Cal users' meeting in Copenhagen, Denmark.

12-15 November 2011

Beactica participates at Developments in Protein Interaction Analysis (DiPIA) in Boston, USA.

31 oct-2 Nov 2011

Beactica participates in BIO-Europe 2011 in Düsseldorf, Germany.

8-9 June 2011

Beactica participates in 12th Annual Drug Discovery Leader Summit in Zürich, Switzerland.

6-8 June 2011

Beactica presents at CHI's 9th Annual Next-Gen Kinase Inhibitors in Cambridge, MA.

25 May 2011, 11 am EDT

Beactica's CSO holds webinar hosted by Biacore Life Sciences, GE Healthcare.

12-14 April 2011

Beactica presents at CHI's 6th Annual Drug Discovery Chemistry Conference in San Diego, CA.

22-23 March 2011

Beactica Principal Scientist presents at the 10th Annual Target & Tools: Protein Kinases Conference in Berlin, Germany.

2-3 Nov 2009

Beactica participates in BIO-Europe Partnering 2009 in Vienna, Austria.

10-13 October 2010

Beactica participates in Fragment-Based Lead Generation 2010 in Philadelphia,PA.

12-16 September 2010

Beactica's CSO presents at the National Meeting on Medicinal Chemistry in Padova, Italy.

9-10 Juni 2010

Beactica's CEO speaks at the 11th Annual Drug Discovery Leaders Summit in Montreaux, Switzerland.

27-28 May 2010

Beactica Senior Scientist presents at The 5th Annual Protein Kinases in Drug Discovery Conference in Boston, USA.

27-28 May 2010

Beactica Senior Scientist presents at the 5th Annual Protein Kinases in Drug Discovery Conference in Boston, USA:

27-29 April 2010

Beactica Senior Scientist presents at Drug Discovery Chemistry 2010 in San Diego, CA.

22-25 March 2010

Beactica’s CSO presents at The International Workshop on New Approaches in Drug Design & Discovery in Schloss Rauischholzhausen, Germany.

21-23 Sept 2009

Beactica presents a poster at Fragment-Based Lead Discovery 2009 in York, UK.

19-24 July 2009

Beactica’s CSO presents at the Gordon Research Conference on Computer-Aided Drug Design in Tilton, USA.

26 June 2009

Beactica’s CSO presents at Fragment-Based Lead Discovery Summit in London, UK.

15-16 June 2009

Beactica’s CSO presents at 10th Annual Drug Discovery Leaders Summit in Montreaux, Switzerland.

3-8 May 2009

Beactica’s CSO presents at Trends in Drug Research, the 27th Noordwijkerhout-Camerino-Cyprus Conference in Noordwijkerhout, The Netherlands.

6-8 April 2009

Beactica’s CSO presents at Drug Discovery Chemistry 2009 in San Diego, USA.

4-5 March 2009

Beactica participates in Fragments 2009 in Alderley Park, UK.

24-25 Feb 2009

Beactica Senior Scientist presents at BIOPROSP 2009 in Tromsoe, Norway.

8 Oct 2008

Beactica’s CSO is part of expert commentary panel on the Nobel Committee’s press conference in conjunction with the announcement of the 2008 Nobel Prize in Chemistry.

23-24 Sept 2008

Beactica’s CEO presents at Drug Discovery 2008 in Bournemouth, UK.

17-20 June 2008

Beactica participates in Business Forum Partnering at BIO 2008 in San Diego, USA.

10-11 Juni 2008

Beactica participates in Label Free Technologies in Drug Discovery in Dresden, Germany.

27 May 2008

Beactica’s CEO presents at Drug Discovery Chemistry 2008 – Tools, Targets & Therapies in La Jolla, USA.

27-30 April 2008

Beactica participates in Drug Discovery Chemistry 2008 in La Jolla, USA.

7-9 April 2008

Beactica participates in BIO-Europe Spring 2008 in Madrid, Spain.

18-20 February 2008

Beactica participates in Fragment-Based Lead Discovery Conference 2008 in San Diego, USA.

24-26 Sept 2007

Beactica participates in Biotech Forum Partnering 2007 in Stockholm, Sweden.

18 Juni 2007

Beactica’s CSO presents at The 8th Drug Discovery Leaders Summit in Berlin, Germany.

6-9 May 2007

Beactica’s CSO presents a fragment-based lead discovery project at DiPIA 2007 in Phoenix, Arizona.

5-9 May 2007

Beactica participates in the Swedish Trade Council’s Scandinavian Pavilion at the biotech world’s largest partnering and networking meeting, BIO 2007, in Boston, Massachusetts.

8 Nov 2006

Beactica wins business competition organised by VINNOVA (Swedish Governmental Agency for Innovation Systems) and receives funding.

27-28 Feb 2006

Beactica participates in an official trade mission to Belgium organized by the Walloon Export & Foreign Investments Agency.